Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges - Scorecard - MDSpire

Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges

  • By

  • Sirajunisa Talath

  • Mohamed El-Tanani

  • Adil Farooq Wali

  • Syed Arman Rabbani

  • Bhoomendra Bhongande

  • Walaa Ibraheem

  • Ashot Avagimyan

  • Karolina Hoffmann

  • Ioannis Ilias

  • Sorina Ispas

  • Maggio Viviana

  • Anna Paczkowska

  • Manfredi Rizzo

  • April 30, 2026

  • 0 min

Share

Clinical Scorecard: Complementary Natural Supplements in Breast Cancer Treatment: Evidence from Research, Safety Considerations, and New Challenges

At a Glance

CategoryDetail
ConditionBreast Cancer
Key MechanismsAntioxidants, anti-inflammatory agents, apoptotic inductors, hormonal modulators
Target PopulationWomen diagnosed with breast cancer
Care SettingOncology clinics and integrative medicine settings

Key Highlights

  • Breast cancer is the most frequent cancer among women globally.
  • Natural supplements may modulate therapeutic response and influence treatment-related toxicity.
  • Robust clinical evidence for the efficacy of natural supplements remains limited.
  • Standardization and bioavailability issues hinder clinical translation.
  • Future studies should focus on dosing personalization and integration with precision oncology.

Guideline-Based Recommendations

Diagnosis

  • Consider molecular and genetic variability among breast cancer subtypes.

Management

  • Integrate natural supplements with conventional therapies cautiously.

Monitoring & Follow-up

  • Establish pharmacovigilance systems for natural supplement use.

Risks

  • Be aware of potential herb-drug interactions and safety concerns.

Patient & Prescribing Data

Women with varying subtypes of breast cancer, including HR-positive, HER2-enriched, and TNBC.

Natural supplements may provide additional benefits but require careful consideration of safety and efficacy.

Clinical Best Practices

  • Promote interdisciplinary collaboration among clinicians, pharmacologists, and traditional medicine scientists.
  • Adhere to evidence-based practices when incorporating natural supplements.

References

Original Source(s)

Related Content